Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis

Lancet Neurology
Daniel OntanedaNikos Evangelou

Abstract

Treatment decisions in multiple sclerosis are complex given the large number of disease-modifying therapies with diverse safety and efficacy profiles. The importance of early treatment has been recognised but how intensively to treat at onset is not known. Substantial variability exists in treatment selection with weak clinical trial evidence to guide initial treatment choices. Decision-making is made more complicated by variable tolerance for risk of side-effects and inability to accurately predict treatment response. Whether to use moderately effective and safe medications with escalation as needed, or to use higher efficacy medications from the outset, is a key question in clinical practice. Clinical trials in patients with relapsing multiple sclerosis have focused on pairwise comparisons but the effectiveness of different treatment approaches has not been tested. Future pragmatic randomised clinical trials and observational studies will help to inform more rational selection of initial therapies and improve the quality of life of patients with relapsing multiple sclerosis.

Citations

Jan 25, 2020·Journal of Neurology, Neurosurgery, and Psychiatry·Luca ProsperiniClaudio Gasperini
Feb 23, 2020·Multiple Sclerosis : Clinical and Laboratory Research·Celia Oreja-Guevara
Mar 4, 2020·Multiple Sclerosis : Clinical and Laboratory Research·Nikos Evangelou, Daniel Ontaneda
Apr 21, 2020·Expert Review of Neurotherapeutics·Eleonora TavazziNiels Bergsland
Apr 11, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Iciar Martínez-LópezMontserrat Pérez-Encinas
Dec 21, 2019·The Mental Health Clinician·Shilpa Klocke, Nicole Hahn
Jun 13, 2020·Multiple Sclerosis : Clinical and Laboratory Research·Georgina ArrambideUNKNOWN 2018 ECTRIMS Focused Workshop Group
Jan 21, 2020·Frontiers in Immunology·Manolo SambucciGiovanna Borsellino
Jul 4, 2020·Degenerative Neurological and Neuromuscular Disease·Carolyn H Goldschmidt, Le H Hua
May 28, 2020·Biomedicines·Mariano MarrodanJorge Correale
Nov 6, 2020·Journal of Clinical Medicine·Sara ScuteraValeria Allizond
Dec 18, 2019·Multiple Sclerosis and Related Disorders·Maria A TerzaghiGustavo Saposnik
Dec 19, 2020·Therapeutic Advances in Neurological Disorders·Thomas BergerEva Kubala Havrdová
Dec 31, 2020·Vaccines·Georges JalkhMary Rensel
Feb 25, 2021·Annals of Clinical and Translational Neurology·Yuri AhujaZongqi Xia
Mar 3, 2021·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Xavier MoissetUNKNOWN OFSEP investigators
Mar 13, 2021·Current Opinion in Neurology·Sarah B SimmonsDaniel Ontaneda
May 4, 2021·Current Opinion in Neurology·Per S Sørensen
May 30, 2021·Neurology. Neuroimmunology and Neuroinflammation·Klaus BerekHarald Hegen
Jul 4, 2021·Multiple Sclerosis and Related Disorders·Mahdi BarzegarVahid Shaygannejad
Jul 24, 2021·Der Nervenarzt·Heinz WiendlUNKNOWN die Multiple Sklerose Therapie Konsensus Gruppe (MSTKG)
Jul 25, 2021·Neurology. Neuroimmunology and Neuroinflammation·Enric MonrealLuisa María Villar
Aug 3, 2021·Multiple Sclerosis and Related Disorders·Pablo A LópezEdgar Carnero Contentti
Aug 2, 2021·Journal of the Neurological Sciences·R Skipper Plowman, Hemant Varma
Aug 25, 2021·Der Nervenarzt·Ralf A Linker, Ralf Gold
Aug 24, 2021·Therapeutic Advances in Neurological Disorders·Heinz WiendlUNKNOWN ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG)
Nov 9, 2021·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Patrick VermerschUNKNOWN CASTING Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.